Syra Health FY2025 net loss down 76%; Population Health revenue up 157% to $5.3M

Syra Health Corp

FY2025 revenue $7.2M (-9% YoY); net loss improved 76% to ($896K) from ($3.8M).
EPS improved to ($0.08) from ($0.50) in FY2024; Q4 2025 net loss ($135K) vs ($504K) Q4 2024.
Population Health revenue grew 157% to $5.3M; gross margin expanded to 34.4% from 20.7%.
Operating expenses down 37% to $3.4M; adjusted EBITDA improved to ($863K) from ($3.7M).
Company expects profitability by year-end 2026; cash $1.6M, no long-term debt.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.